American International Group, Inc. Aura Biosciences, Inc. Transaction History

American International Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.09 - $9.24 $26,814 - $34,945	3,782 Added 27.41%	17,579 $137,000
Q4 2023 Feb 13, 2024	BUY	$7.02 - $11.98 $617 - $1,054	88 Added 0.64%	13,797 $122,000
Q3 2023 Nov 13, 2023	BUY	$8.97 - $12.38 $4,377 - $6,041	488 Added 3.69%	13,709 $122,000
Q2 2023 Aug 04, 2023	BUY	$8.51 - $13.33 $15,360 - $24,060	1,805 Added 15.81%	13,221 $163,000
Q1 2023 May 12, 2023	BUY	$8.88 - $12.11 $24,402 - $33,278	2,748 Added 31.7%	11,416 $105,000
Q4 2022 Feb 10, 2023	SELL	$9.86 - $14.59 $315 - $466	-32 Reduced 0.37%	8,668 $91,000
Q3 2022 Nov 14, 2022	BUY	$13.1 - $20.34 $1,611 - $2,501	123 Added 1.43%	8,700 $158,000
Q2 2022 Aug 12, 2022	BUY	$12.37 - $21.86 $71,684 - $126,678	5,795 Added 208.3%	8,577 $122,000
Q1 2022 May 13, 2022	SELL	$15.94 - $23.34 $1,833 - $2,684	-115 Reduced 3.97%	2,782 $61,000
Q4 2021 Feb 11, 2022	BUY	$14.76 - $24.89 $42,759 - $72,106	2,897 New	2,897 $49,000

40.4M

800

1.8K

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $264M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.